SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials -- Ignore unavailable to you. Want to Upgrade?


To: William Stanton who wrote (20)6/9/1999 6:02:00 PM
From: glen  Read Replies (1) | Respond to of 250
 
I do like your guesswork and I most definitely hope that your numbers are indeed in the ballpark. However, this is not an internet stock, and being that Phase III Trials can last 30-36 months, I would be surprised to see it higher than the mid 20's. I'd be happy if you are right and I am wrong, though.

Regards,
glen



To: William Stanton who wrote (20)6/22/1999 6:08:00 PM
From: glen  Respond to of 250
 
<<VAXGEN IPO SCHEDULED FOR JUNE 29, 1999>>



To: William Stanton who wrote (20)6/26/1999 1:12:00 AM
From: glen  Read Replies (1) | Respond to of 250
 
There will be no need to guess the price in a few days. The VaxGen IPO will be priced on Monday, and will begin trading this Tuesday, June 29. Allocation at Prudential appears to be limited and tight.



To: William Stanton who wrote (20)6/29/1999 12:09:00 PM
From: glen  Respond to of 250
 
This time tomorrow we won't have to guess about VaxGen. Prudential has already done their branch allocations today. This afternoon the IPO shares will be priced, and, it's off to the races tomorrow morning when VXGN begins it's trading debut.